BC3 Technologies' Seed Round

BC3 Technologies raised a round of funding on February 05, 2018. Investors include Quake Capital.

BC3 Technologies' proprietary chitosan-based aerosol product allows for easy application to wounds as well as increased clotting ability for the medical, military, and general consumer sectors.…

Articles about BC3 Technologies' Seed Round: